Tag: Biotechnology

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC

Jim Cramer says this former Covid market darling is finally investable again

Medicare will start covering obesity drugs for the first time. Here’s what patients should know

Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet

Chan Zuckerberg Initiative’s Biohub to open new rare disease funding round

Zealand Pharma stock suffered its two worst days on record. Here’s what’s next for the weight loss drugmaker

Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC

Centene to offer buyouts to some employees as health insurer cuts costs

Food supply ‘not at risk’ after new Texas screwworm cases, USDA secretary says

Weight loss drug maker sinks 25% after new safety data spooks investors